Perspective Therapeutics (CATX) Gains from Investment Securities (2016 - 2025)
Historic Gains from Investment Securities for Perspective Therapeutics (CATX) over the last 14 years, with Q3 2025 value amounting to -$14000.0.
- Perspective Therapeutics' Gains from Investment Securities changed N/A to -$14000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 billion, marking a year-over-year increase of 22721.85%. This contributed to the annual value of $7.4 million for FY2024, which is 4379.33% up from last year.
- According to the latest figures from Q3 2025, Perspective Therapeutics' Gains from Investment Securities is -$14000.0.
- Perspective Therapeutics' 5-year Gains from Investment Securities high stood at $2.0 billion for Q4 2024, and its period low was -$305000.0 during Q4 2022.
- Moreover, its 5-year median value for Gains from Investment Securities was $2.5 million (2021), whereas its average is $193.6 million.
- Per our database at Business Quant, Perspective Therapeutics' Gains from Investment Securities soared by 19997606.56% in 2023 and then crashed by 36000.0% in 2025.
- Perspective Therapeutics' Gains from Investment Securities (Quarter) stood at $7.3 million in 2021, then crashed by 104.2% to -$305000.0 in 2022, then soared by 199976.07% to $609.6 million in 2023, then skyrocketed by 227.24% to $2.0 billion in 2024, then crashed by 100.0% to -$14000.0 in 2025.
- Its Gains from Investment Securities stands at -$14000.0 for Q3 2025, versus -$84000.0 for Q2 2025 and -$138000.0 for Q1 2025.